uu.seUppsala universitets publikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Ebselen and analogs as inhibitors of Bacillus anthracis thioredoxin reductase and bactericidal antibacterials targeting Bacillus species, Staphylococcus aureus and Mycobacterium tuberculosis
Karolinska Inst, Div Biochem, Dept Med Biochem & Biophys, Scheeles Vag 2, SE-17177 Stockholm, Sweden.; Umea Univ, Sunderby Res Unit, Dept Clin Microbiol, Clin Bacteriol, Umea, Sweden.
Karolinska Inst, Div Biochem, Dept Med Biochem & Biophys, Scheeles Vag 2, SE-17177 Stockholm, Sweden.
Publ Hlth Agcy Sweden, Dept Microbiol, Solna, Sweden.
Publ Hlth Agcy Sweden, Dept Microbiol, Solna, Sweden.
Vise andre og tillknytning
2016 (engelsk)Inngår i: Biochimica et Biophysica Acta - General Subjects, ISSN 0304-4165, E-ISSN 1872-8006, Vol. 1860, nr 6, s. 1265-1271Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Background: Bacillus anthracis is the causative agent of anthrax, a disease associated with a very high mortality rate in its invasive forms.

Methods: We studied a number of ebselen analogs as inhibitors of B. anthracis thioredoxin reductase and their antibacterial activity on Bacillus subtilis, Staphylococcus aureus, Bacillus cereus and Mycobacterium tuberculosis.

Results: The most potent compounds in the series gave IC50 values down to 70 nM for the pure enzyme and minimal inhibitory concentrations (MICs) down to 0.4 mu M (0.12 mu g/ml) for B. subtilis,1.5 mu M (0.64 mu g/ml) for S. aureus, 2 mu M (0.86 mu g/ml) for B. cereus and 10 mu g/ml for M. tuberculosis. Minimal bactericidal concentrations (MBCs) were found at 1-1.5 times the MIC, indicating a general, class-dependent, bactericidal mode of action. The combined bacteriological and enzymological data were used to construct a preliminary structure-activity-relationship for the benzoisoselenazol class of compounds. When S. aureus and B. subtilis were exposed to ebselen, we were unable to isolate resistant mutants on both solid and in liquid medium suggesting a high resistance barrier.

Conclusions: These results suggest that ebselen and analogs thereof could be developed into a novel antibiotic class, useful for the treatment of infections caused by B. anthracis, S. aureus, M. tuberculosis and other clinically important bacteria. Furthermore, the high barrier against resistance development is encouraging for further drug development.

General significance: We have characterized the thioredoxin system from B. anthracis as a novel drug target and ebselen and analogs thereof as a potential new class of antibiotics targeting several important human pathogens.

sted, utgiver, år, opplag, sider
2016. Vol. 1860, nr 6, s. 1265-1271
HSV kategori
Identifikatorer
URN: urn:nbn:se:uu:diva-282979DOI: 10.1016/j.bbagen.2016.03.013ISI: 000375165300022PubMedID: 26971857OAI: oai:DiVA.org:uu-282979DiVA, id: diva2:918010
Forskningsfinansiär
Swedish Research CouncilTilgjengelig fra: 2016-04-08 Laget: 2016-04-08 Sist oppdatert: 2017-11-30bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekstPubMed

Personposter BETA

Engman, Lars

Søk i DiVA

Av forfatter/redaktør
Engman, Lars
Av organisasjonen
I samme tidsskrift
Biochimica et Biophysica Acta - General Subjects

Søk utenfor DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 631 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf